Fig. 1From: The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population: a comparative observational studyKaplan–Meier estimates of cumulative recoveries and mortality by 14 days. Estimates of cumulative recoveries (a) and mortality by 14 days (b) for patients in the Capital Region of Denmark and the placebo group in the ACTT-1 studyBack to article page